InsiderDB

Lobbying disclosures · Lobbying report

CAH: second_quarter 2026 lobbying report

Issues related to the distribution and sale of pharmaceutical and medical products and services; medical and public health preparedness; drug shortages; Food as Medicine; and the healthcare supply chain. Issues related to the distribution and sale of pharmaceutical and medical products and services; medical and public health preparedness; drug shortages; Food as Medicine; and the healthcare supply chain. Issues related to the distribution and sale of pharmaceutical and medical products and services; medical and public health preparedness; drug shortages; and the healthcare supply chain. Issues

Follow CAH
Became public
Jul 20, 2026, 9:58 AM EDT
Event / period date
Not stated
Collected
Nov 10, 2026, 6:50 AM EST

Why this is connected

Exact legal-name match: CARDINAL HEALTH INC (https://www.sec.gov/Archives/edgar/data/721371/).

Reported lobbying amounts

Income: $24,000.00

These are different reporting measures. They are not added together or treated as spending on one particular bill.

Source evidence

Read the source excerpt or record
{"url":"https://lda.gov/api/v1/filings/5a548441-720b-40fe-83fa-2a8a2ab278a7/","filing_uuid":"5a548441-720b-40fe-83fa-2a8a2ab278a7","filing_type":"2T","filing_type_display":"2nd Quarter - Termination","filing_year":2026,"filing_period":"second_quarter","filing_period_display":"2nd Quarter (Apr 1 - June 30)","filing_document_url":"https://lda.gov/filings/public/filing/5a548441-720b-40fe-83fa-2a8a2ab278a7/print/","filing_document_content_type":"text/html","income":"24000.00","expenses":null,"expenses_method":null,"expenses_method_display":null,"posted_by_name":"Lisa D Rulli","dt_posted":"2026-07-20T09:58:14-04:00","termination_date":"2026-06-30","registrant_country":"United States of America","registrant_ppb_country":null,"registrant_address_1":"434 New Jersey Avenue, S.E.","registrant_address_2":null,"registrant_different_address":false,"registrant_city":"Washington","registrant_state":"DC","registrant_zip":"20003","registrant":{"id":38687,"url":"https://lda.gov/api/v1/registrants/38687/","house_registrant_id":33675,"name":"TWENTY-FIRST CENTURY GROUP, INC.","description":"Political Consulting/Government Affairs","address_1":"434 New Jersey Avenue, S.E.","address_2":null,"address_3":null,"address_4":null,"city":"Washington","state":"DC","state_display":"District of Columbia","zip":"20003","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"LISA RULLI","contact_telephone":"+1 202-488-2800","dt_updated":"2026-07-30T15:55:39.536174-04:00"},"client":{"id":146957,"url":"https://lda.gov/api/v1/clients/146957/","client_id":595,"name":"CARDINAL HEALTH, INC.","general_description":"Health care services company.","client_government_entity":false,"client_self_select":null,"state":"OH","state_display":"Ohio","country":"US","country_display":"United States of America","ppb_state":"OH","ppb_state_display":"Ohio","ppb_country":"US","ppb_country_display":"United States of America","effective_date":"2016-09-01"},"lobbying_activities":[{"general_issue_code":"HCR","general_issue_code_display":"Health Issues","description":"Issues related to the distribution and sale of pharmaceutical and medical products and services; medical and public health preparedness; drug shortages; Food as Medicine; and the healthcare supply chain.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":25252,"prefix":null,"prefix_display":null,"first_name":"JACK","nickname":null,"middle_name":null,"last_name":"FIELDS","suffix":null,"suffix_display":null},"covered_position":"Former Member of Congress","new":false},{"lobbyist":{"id":63029,"prefix":null,"prefix_display":null,"first_name":"LISA","nickname":null,"middle_name":"D","last_name":"RULLI","suffix":null,"suffix_display":null},"covered_position":"Former Staffer, Committee on Merchant Marine & Fisheries; Committee on Natural Resources","new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"PHA","general_issue_code_display":"Pharmacy","description":"Issues related to the distribution and sale of pharmaceutical and medical products and services; medical and public health preparedness; drug shortages; Food as Medicine; and the healthcare supply chain.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":25252,"prefix":null,"prefix_display":null,"first_name":"JACK","nickname":null,"middle_name":null,"last_name":"FIELDS","suffix":null,"suffix_display":null},"covered_position":"Former Member of Congress","new":false},{"lobbyist":{"id":63029,"prefix":null,"prefix_display":null,"first_name":"LISA","nickname":null,"middle_name":"D","last_name":"RULLI","suffix":null,"suffix_display":null},"covered_position":"Former Staffer, Committee on Merchant Marine & Fisheries; Committee on Natural Resources","new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"DIS","general_issue_code_display":"Disaster Planning/Emergencies","description":"Issues related to the distribution and sale of pharmaceutical and medical products and services; medical and public health preparedness; drug shortages; and the healthcare supply chain.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":25252,"prefix":null,"prefix_display":null,"first_name":"JACK","nickname":null,"middle_name":null,"last_name":"FIELDS","suffix":null,"suffix_display":null},"covered_position":"Former Member of Congress","new":false},{"lobbyist":{"id":63029,"prefix":null,"prefix_display":null,"first_name":"LISA","nickname":null,"middle_name":"D","last_name":"RULLI","suffix":null,"suffix_display":null},"covered_position":"Former Staffer, Committee on Merchant Marine & Fisheries; Committee on Natural Resources","new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"BUD","general_issue_code_display":"Budget/Appropriations","description":"Issues related to the distribution and sale of pharmaceutical and medical products and services; medical and public health preparedness; drug shortages; Food as Medicine; and the healthcare supply chain.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":25252,"prefix":null,"prefix_display":null,"first_name":"JACK","nickname":null,"middle_name":null,"last_name":"FIELDS","suffix":null,"suffix_display":null},"covered_position":"Former Member of Congress","new":false},{"lobbyist":{"id":63029,"prefix":null,"prefix_display":null,"first_name":"LISA","nickname":null,"middle_name":"D","last_name":"RULLI","suffix":null,"suffix_display":null},"covered_position":"Former Staffer, Committee on Merchant Marine & Fisheries; Committee on Natural Resources","new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"TAR","general_issue_code_display":"Tariff (miscellaneous tariff bills)","description":"Tariff-related matters regarding the distribution and sale of pharmaceutical and medical products and the healthcare supply chain.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":25252,"prefix":null,"prefix_display":null,"first_name":"JACK","nickname":null,"middle_name":null,"last_name":"FIELDS","suffix":null,"suffix_display":null},"covered_position":"Former Member of Congress.","new":false},{"lobbyist":{"id":63029,"prefix":null,"prefix_display":null,"first_name":"LISA","nickname":null,"middle_name":"D","last_name":"RULLI","suffix":null,"suffix_display":null},"covered_position":"Former staffer, Committee on Merchant Marine & Fisheries, Committee on Natural Resources","new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]}],"conviction_disclosures":[],"foreign_entities":[],"affiliated_organizations":[]}

Congressional trading in CAH

These disclosures provide context. Their presence does not establish a link between a trader and the event.

Original documents control. Public records can be amended, and company connections may require interpretation. Nothing here is investment advice.